Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tonifying Qi and Activating Blood Chinese herbal prescriptions for ischemic stroke
ChiCTR2000039941Phase 4Recruiting
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Dec 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of buyang huanwu decoction, naoxintong, yangyintongnao and Placebo-COD Research Private Ltd in ischemic stroke (4 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Modified Rankin Scale and Effective rate of syndrome of qi deficiency and blood stasis. Started Dec 2020; status: recruiting.
02
Drugs
buyang huanwu decoctionnaoxintongyangyintongnaoPlacebo-COD Research Private Ltd
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2000039941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039941.